Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study.
Barror S, Avramovic G, Oprea C, Surey J, Story A, Macías J, Cullen W, Crowley D, Horan A, Naughton AM, Iglesias M, Ianache I, Lazar S, Popa I, McHugh T, Menezes D, Tinago W, Lambert JS. Barror S, et al. Among authors: macias j. J Antimicrob Chemother. 2019 Nov 1;74(Suppl 5):v39-v46. doi: 10.1093/jac/dkz455. J Antimicrob Chemother. 2019. PMID: 31782499 Free PMC article.
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.
Mira JA, Macías J, Girón-González JA, Merino D, González-Serrano M, Jiménez-Mejías ME, Caballero-Granado FJ, Torre-Cisneros J, Terrón A, Becker MI, Gómez-Mateos J, Arizcorreta-Yarza A, Pineda JA; Grupo Andaluz Para el Estudio de las Enfermedades Infecciosas (GAEI). Mira JA, et al. Among authors: macias j. J Antimicrob Chemother. 2006 Jul;58(1):140-6. doi: 10.1093/jac/dkl214. Epub 2006 May 23. J Antimicrob Chemother. 2006. PMID: 16720565
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.
Macías J, Orihuela F, Rivero A, Viciana P, Márquez M, Portilla J, Ríos MJ, Muñoz L, Pasquau J, Castaño MA, Abdel-Kader L, Pineda JA; Hepatip Study Group. Macías J, et al. J Antimicrob Chemother. 2009 Jan;63(1):178-83. doi: 10.1093/jac/dkn429. Epub 2008 Oct 24. J Antimicrob Chemother. 2009. PMID: 18952618
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
Neukam K, Mira JA, Ruiz-Morales J, Rivero A, Collado A, Torres-Cornejo A, Merino D, de Los Santos-Gil I, Macías J, González-Serrano M, Camacho A, Parra-García G, Pineda JA; SEGURIDAD HEPÁTICA Study Team of the Grupo HEPAVIR de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Neukam K, et al. Among authors: macias j. J Antimicrob Chemother. 2011 Nov;66(11):2605-14. doi: 10.1093/jac/dkr357. Epub 2011 Sep 7. J Antimicrob Chemother. 2011. PMID: 21903660
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients.
Neukam K, Almeida C, Caruz A, Rivero-Juárez A, Rallón NI, Di Lello FA, Herrero R, Camacho A, Benito JM, Macías J, Rivero A, Soriano V, Pineda JA. Neukam K, et al. Among authors: macias j. J Antimicrob Chemother. 2013 Apr;68(4):915-21. doi: 10.1093/jac/dks488. Epub 2012 Dec 12. J Antimicrob Chemother. 2013. PMID: 23243129
Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol.
Swan D, Cullen W, Macias J, Oprea C, Story A, Surey J, Vickerman P, Lambert JS. Swan D, et al. Among authors: macias j. Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):303-314. doi: 10.1080/17474124.2018.1424541. Epub 2018 Jan 16. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29300496 Free article.
Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series.
McCombe G, Almaazmi B, Cullen W, Lambert JS, Avramovic G, Murphy C, O'Connor M, Perry N, Ianache I, Lazar S, McHugh T, Surey J, Macías J, Vickerman P, Oprea C. McCombe G, et al. Among authors: macias j. J Antimicrob Chemother. 2019 Nov 1;74(Suppl 5):v24-v30. doi: 10.1093/jac/dkz453. J Antimicrob Chemother. 2019. PMID: 31782501 Free PMC article.
Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care.
Nic An Riogh E, Swan D, McCombe G, O'Connor E, Avramovic G, Macías J, Oprea C, Story A, Surey J, Vickerman P, Ward Z, Lambert JS, Tinago W, Ianache I, Iglesias M, Cullen W. Nic An Riogh E, et al. Among authors: macias j. J Antimicrob Chemother. 2019 Nov 1;74(Suppl 5):v31-v38. doi: 10.1093/jac/dkz454. J Antimicrob Chemother. 2019. PMID: 31782502 Free PMC article.
487 results